insights_auto
Why is ZLDPF up 4.99%?
Dive Deeperchevron_right
ZLDPF:OTCMKTS
Zealand Pharma A/S
$40.00
arrow_upward
+4.99%(+1.90) 1D
Oct 2, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZLDPF...
Open
$36.80
High
$40.00
Low
$36.80
Mkt. cap
2.74B
Avg. vol.
705.00
Volume
2.10K
52-wk high
$83.12
52-wk low
$35.93
Beta
1.23
Shares outstanding
71.61M
No. of employees
578
Open
$36.80
High
$40.00
Low
$36.80
Mkt. cap
2.74B
Avg. vol.
705.00
Volume
2.10K
52-wk high
$83.12
52-wk low
$35.93
Beta
1.23
Shares outstanding
71.61M
No. of employees
578
News stories
From web sources and news partners
Investing.com
·
1 day ago
Premarket movers: Alphabet rises on new AI model, Zealand Pharma sinks
Investing.com
·
2 days ago
Zealand Pharma shares fall 12% after obesity drug trial flags side effects
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S
CEOAdam Steensberg
Employees578
FoundedApr 1, 1997
Headquarters-
SectorBiotechnology
Websitezealandpharma.com